Systemic treatment of metastatic breast cancer

Leona Downey, Robert B. Livingston

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Marked advancements are being made in the treatment of early-stage breast cancer, but many women still develop recurrence and metastasis. In addition, 5-10% of breast cancer patients have metastatic disease at presentation. While treatments for metastatic breast cancer continue to improve, there remains no cure once distant metastases develop, and over 40,000 women die of advanced disease annually in the United States alone. Balancing therapeutic efficacy in relation to side effects is critical. This chapter provides an overview of systemic therapy options for patients with metastatic breast cancer.

Original languageEnglish (US)
Title of host publicationBreast Surgical Techniques and Interdisciplinary Management
PublisherSpringer New York
Pages1039-1044
Number of pages6
ISBN (Print)9781441960757
DOIs
StatePublished - Dec 1 2011

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Systemic treatment of metastatic breast cancer'. Together they form a unique fingerprint.

  • Cite this

    Downey, L., & Livingston, R. B. (2011). Systemic treatment of metastatic breast cancer. In Breast Surgical Techniques and Interdisciplinary Management (pp. 1039-1044). Springer New York. https://doi.org/10.1007/978-1-4419-6076-4_86